Stay updated on Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial

Sign up to get notified when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.
Clouds background image

Latest updates to the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page

  1. Check
    56 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.0%
    Check dated 2025-01-18T21:41:04.000Z thumbnail image
  2. Check
    67 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    0.1%
    Check dated 2025-01-07T17:49:15.000Z thumbnail image
  3. Check
    88 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.0%
    Check dated 2024-12-17T07:28:06.000Z thumbnail image
  4. Check
    96 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.
    Difference
    1%
    Check dated 2024-12-09T22:33:31.000Z thumbnail image
  5. Check
    110 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.1 to v2.12.2.
    Difference
    0.0%
    Check dated 2024-11-25T13:55:29.000Z thumbnail image
  6. Check
    131 days ago
    Change Detected
    Summary
    New entries for Alfasigma S.p.A. and its Study Director have been added, while Galapagos NV and Gilead Sciences have been removed from the list.
    Difference
    0.7%
    Check dated 2024-11-04T09:30:16.000Z thumbnail image

Stay in the know with updates to Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Filgotinib in RA: Safety & Efficacy (FINCH 4) Clinical Trial page.